​

Tenaya Therapeutics (TNYA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

TNYA Stock Forecast

Tenaya Therapeutics (TNYA) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $2.50, with a high of $3.00 and a low of $2.00. This represents a 252.11% increase from the last price of $0.71.

- $1 $2 $3 $4 $5 $6 High: $3 Avg: $2.5 Low: $2 Last Closed Price: $0.71

TNYA Stock Rating

Tenaya Therapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

TNYA Price Target Upside V Benchmarks

TypeNameUpside
StockTenaya Therapeutics252.11%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts122
Avg Price Target$2.00$2.50$2.50
Last Closing Price$0.71$0.71$0.71
Upside/Downside181.69%252.11%252.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2626---8
Dec, 2527---9
Nov, 2536---9
Oct, 2536---9
Sep, 2536---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 08, 2026Morgan Stanley$2.00$0.80150.00%181.69%
Dec 12, 2025H.C. Wainwright$3.00$0.88240.91%322.54%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 18, 2025Canaccord GenuityBuyBuyhold
Dec 15, 2025H.C. WainwrightBuyBuyhold
Oct 18, 2024Piper SandlerOverweightOverweighthold
Oct 18, 2024H.C. WainwrightBuyBuyhold
Oct 18, 2024Leerink PartnersOutperformOutperformhold
Oct 01, 2024Canaccord GenuityBuyBuyhold
Jul 08, 2024H.C. WainwrightBuyBuyhold
Jun 10, 2024William BlairOutperforminitialise
May 16, 2024Canaccord GenuityBuyBuyhold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.68$-1.31----
Avg Forecast$-1.69$-1.35$-1.25$-1.28$0.44$3.18
High Forecast$-1.55$-1.29$-1.04$-0.72$1.96$4.43
Low Forecast$-1.79$-1.39$-1.40$-1.67$-1.18$1.92
Surprise %-0.59%-2.96%----

Revenue Forecast

$0 $200M $400M $600M $800M $1B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$833.33K$3.29M$32.61M$266.42M$746.32M
High Forecast-$1.09M$4.29M$42.53M$266.42M$973.46M
Low Forecast-$579.71K$2.29M$22.68M$266.41M$519.18M
Surprise %------

Net Income Forecast

$-150M $-50M $50M $150M $250M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-124.08M$-111.13M----
Avg Forecast$-124.08M$-98.93M$-90.06M$-121.27M$53.16M$234.46M
High Forecast$-114.56M$-95.24M$-76.57M$-52.89M$144.30M$327.22M
Low Forecast$-132.41M$-102.62M$-103.55M$-122.88M$-86.74M$141.69M
Surprise %-12.33%----

TNYA Forecast FAQ

Is Tenaya Therapeutics stock a buy?

Tenaya Therapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Tenaya Therapeutics is a favorable investment for most analysts.

What is Tenaya Therapeutics's price target?

Tenaya Therapeutics's price target, set by 6 Wall Street analysts, averages $2.5 over the next 12 months. The price target range spans from $2 at the low end to $3 at the high end, suggesting a potential 252.11% change from the previous closing price of $0.71.

How does Tenaya Therapeutics stock forecast compare to its benchmarks?

Tenaya Therapeutics's stock forecast shows a 252.11% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Tenaya Therapeutics over the past three months?

  • January 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Tenaya Therapeutics’s EPS forecast?

Tenaya Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.25, marking a -4.58% decrease from the reported $-1.31 in 2024. Estimates for the following years are $-1.28 in 2026, $0.44 in 2027, and $3.18 in 2028.

What is Tenaya Therapeutics’s revenue forecast?

Tenaya Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $3.29M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $32.61M, followed by $266.42M for 2027, and $746.32M for 2028.

What is Tenaya Therapeutics’s net income forecast?

Tenaya Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-90.062M, representing a -18.96% decrease from the reported $-111M in 2024. Projections indicate $-121M in 2026, $53.16M in 2027, and $234.46M in 2028.